A novel method to immobilize bioactive substances on hydrophobic surfaces using a polymerizable cationic lipid

Artificial Organs

Volumn 22, Issue 10, 1998, Pages 873-878

  Yamazaki, Manabu ^a,c   Kobayashi, Ken Yu ^a   Nakai, Tomoko ^a   Mikami, Masato ^a   Yoshioka, Hiroshi ^a   Mori, Yuichi ^a   Satoh, Tadaaki ^b   Kubota, Sunao ^b  

^a W R GRACE AND CO CONN   (United States)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Shuwa Sanhancho Bldg 8F   (Japan)

Author keywords

Cationic charge Heparin; Collagen; Lipid; Surface modification

Indexed keywords

BIOMEDICAL EQUIPMENT; DEPOSITION; HYDROPHOBICITY; POLYSACCHARIDES; SURFACE CHEMISTRY; SURFACE TREATMENT;

ANIONIC GROUPS; BIOACTIVE SUBSTANCES; CATIONIC CHARGE HEPARIN; CATIONIC CHARGES; CATIONIC LIPIDS; HYDROPHOBIC SURFACES; HYDROPHOBICS; NOVEL METHODS; SUCCINYLATED COLLAGEN; SURFACE-MODIFICATION;

COLLAGEN;

ARTICLE; CELL ADHESION; CONFORMATIONAL TRANSITION; HYDROPHOBICITY; MEMBRANE BINDING; MOLECULAR STABILITY; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; THROMBOGENESIS;

EID: 0031657319     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.1998.06074.x     Document Type: Article

References (22)

1. Tanzawa H, Mori Y, Harumiya N, Miyama H, Hori M, Oshima N, Idezuki Y. Preparation and evaluation of a new athrombogenic heparinized hydrophilic polymer for use in cardiovascular system. Trans Am Soc Artif Intern Organs 1973;19:188-44.
2. Larm O, Larsson R, Olsson P. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomater Med Devices Artif Organs 1983;11:161-73.
3. Hsu L-C. Heparin-coating of bypass circuits. Perfusion 1991; 6:209-19.
4. Nagaoka S, Kawakami H. Inhibition of bacterial adhesion and biofilm formation by a heparinized hydrophilic polymer. ASAIO J 1995;41:M365-8.
5. Nagaoka S, Akashi R. Low-friction hydrophilic surface for medical devices. Biomaterials 1990;11:419-24.
6. Ip TK, Aebischer P. Renal epithelial-cell-controlled solute transport across permeable membranes as the foundation for a bioartifical kidney. Artif Organs 1989;13:58-5.
7. Jauregui HO, Naik S, Pan J, Santangini H, Trenkler D, Mullon CJP. Primary cultures of rat hepatocytes in hollow fiber chambers. In Vitro Cell Dev Biol Anim 1994;30A:23-9.
8. Amplatz K. A simple non-thrombogenic coating. Invest Radiol 1971;6:280-9.
9. Toomasian JM, Hsu L-C, Hirschl RB, Heiss KF, Hultquist KA, Bartlett RH. Evaluation of Duraflo II heparin coating in prolonged extracoporeal membrane oxygenation. Trans Am Soc Artif Intern Organs 1988;34:410-4.
10. Palanzo DA, Kurusz M, Butler BD. Surface tension effects of heparin coating on arterial line filters. Perfusion 1990;5: 277-84.
11. Miyata T, Schwartz A, Wang CL, Rubin AL, Stenzel KH. Deposition of platelets and fibrin on chemically modified collagen hollow fibers. Trans Am Soc Artif Intern Organs 1976; 22:261-8.
12. Smith PK, Mallia AK, Mermanson GT. Colorimetric method for the assay of heparin in immobilized heparin preparations. Anal Biochem 1980;109:466-73.
13. Yamamoto K, Kaji K, Kondo H, Matsuo M, Shibata Y, Tasaki Y, Utakoji T, Ooka H. A new human diploid cell strain, TIG-7: Its age-related changes and comparison with a matched female TIG-1 cell strain. Exp Gerontol 1991;26:525-40.
14. Tong S-D, Hsu L-C. Non-thrombogenic hemofiltration system for acute renal failure treatment. ASAIO Trans 1992;38: M702-6.
15. Yamazaki M, Kobayashi K, Mori Y, Satoh T, Kubota S. A novel method to evaluate thromboresistance of drip chambers with filter used in extracorporeal blood circuits for hemodialysis. Artif Organs 1997;21:160-2.
16. Seglen PO. Preparation of isolated rat liver cells. In: Prescott DM, ed. Method in cell biology. Vol. 13. New York: Academic Press, 1976:29-83.
17. Yokoyama K, Kuribayashi T, Hidaka K, Ishida N, Horiuchi K, Nogawa A, Hagiwara K, Kido T, Kijima T, Nojiri C. Prolonged heparin bioactivity of a new heparin bonding method: Comparison between intercapillary and extracapillary blood flow type oxygenator. Jpn J Artif Organs 1995;24:570-5.
18. Dixit V, Piskin E, Arthur M, Denizli A, Tuncel SA, Denkbas E, Gitnick G. Hepatocyte immobilization on PHEMA microcarriers and its biologically modified forms. Cell Transplant 1992;1:391-9.
19. Idezuki Y, Watanabe H, Hagiwara M, Kanasugi K, Mori Y, Nagaoka S, Hagio M, Yamamoto K, Tanzawa H. Mechanism of antithrombogenicity of a new heparinized hydrophilic polymer. Chronic in vivo studies and clinical application. Trans Am Soc Artif Intern Organs 1975;21:436-49.
20. Levine DW, Wang DIC, Thilly WG. Optimization of growth surface parameters in microcarrier cell culture. Biotechnol Bioeng 1979;21:821-45.
21. Hirtenstein M, Clark J, Lindgren G, Vretblad P. Microcarriers for animal cell culture: A brief review of theory and practice. Dev Biol Stand 1980;46:109-16.
22. Akaike T, Kasai S, Nishizawa S, Kobayashi A, Miyata T. Hybrid biomaterials incorporated with living cells in modified collagens. In: Tsuruta T, Nakajima A, eds. Multiphase biomedical materials. Utrecht: VSP BV, 1989:73-87.